[In the Media] “Japan should follow US efforts to develop new antibiotics” (NIKKEI ASIA, July 10, 2021)
date : 8/20/2021
Tags: AMR
On July 10, 2021, Nikkei Asia published an editorial by Mr. Michael W. Hodin, CEO of the Global Coalition on Aging (GCOA), that was written in collaboration with Health and Global Policy Institute (HGPI) – “Japan should follow US efforts to develop new antibiotics.” The editorial discusses the “PASTEUR Act” being proposed in the United States and advocates for greater policy action on the issue of antimicrobial resistance (AMR).
For further information, please see the editorial
Top Research & Recommendations Posts
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)



